ArticleScientific reports2025
A comprehensive analysis of health-related quality of life in thyroid cancer patients using the THYCA-24 questionnaire.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Longitudinal investigation of psychological adaptation and its determinants in primary caregivers following thyroid cancer surgery.Frontiers in medicine · 2026Article
- Post-thyroidectomy anterior neck dysfunction: clinical phenotypes, mechanisms, and comprehensive management.Frontiers in endocrinology · 2026Review
- Factors Associated with Sleep Disruption and Fatigue in Thyroid Cancer Survivors.Current oncology (Toronto, Ont.) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The THYCA-QoL 24 is a specific instrument designed to measure health-related quality of life (HRQoL) in patients with thyroid cancer (TC). This study aimed to evaluate the Vietnamese version of the THYCA-QoL (acceptability, validity, and reliability) and use this validated version to systematically assess longitudinal changes in HRQoL in this patient population before and after thyroidectomy, including adjuvant radioactive iodine (RAI) therapy to understand the impact of surgical intervention over time. The study was conducted in three steps: translation, validation, and evaluation of the THYCA-QoL questionnaire for the Vietnamese population. This process followed the EORTC guidelines. Internal consistency was measured using Cronbach's α, while convergent validity and internal structure of the scale were examined through Pearson correlation analysis. HRQoL data were collected from thyroid cancer patients, at a leading hospital in Southern Vietnam. A cohort comprising 280 patients was enrolled in this study. All participants presented with disease stage I or II at baseline assessment. Evaluation of the psychometric properties of the Vietnamese version of the Thyca-QoL revealed robust internal consistency (Cronbach's alpha = 0.937 for the overall scale) and a satisfactory scale-level Content Validity Index (S-CVI = 0.97). No statistically significant difference was observed in overall QoL scores between the pre-operative baseline and the 3-month post-operative assessment across most physical symptoms. Overall QoL scores did not differ significantly between the radioactive iodine (RAI) treatment group and the non-RAI group; however, within the RAI cohort, QoL impairment was primarily attributable to increased symptom burden, specifically problem swallowing, dry mouth, and abrupt tiredness. Patients undergoing total thyroidectomy reported higher mean symptom scores than those undergoing lobectomy, particularly in domains related to scarring and fatigue (p = 0.001). Multivariate analysis revealed that the presence of comorbidities (p = 0.01) and age (p = 0.04) were independently associated with poorer HRQoL. HRQoL assessment following thyroid cancer surgery is crucial for delivering patient-centered care, improving treatment outcomes, and advancing our understanding of this disease and its consequences for survivors.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.